ArticleBlood advances2025
Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease.
Kristine Karkoska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it